Amanote Research
Register
Sign In
US Agency Wants to Limit Lawsuits Against Drug Manufacturers
BMJ
doi 10.1136/bmj.332.7535.196-d
Full Text
Open PDF
Abstract
Available in
full text
Date
January 28, 2006
Authors
J. Lenzer
Publisher
BMJ
Related search
Congress Turns Spotlight on US Drug Approval Agency
Nature
Multidisciplinary
Bristol-Myers Squibb to Pay $0.5bn to Settle US Lawsuits
BMJ
Safety Agency Wants to Do More to Engage Clinicians, Its Head Says
BMJ
US Panel Wants Global Body to Control Civil Plutonium Use
Nature
Multidisciplinary
Payments by US Pharmaceutical and Medical Device Manufacturers to US Medical Journal Editors: Retrospective Observational Study
British Medical Journal
Medicine
Federal Legislation to Limit Bulk Drug Exports
CMAJ
Medicine
Head of US Environmental Health Agency Resigns
Nature
Multidisciplinary
Civil Liability: Characterization of the Demand for Lawsuits Against Dentists
Brazilian Oral Research
Missouri Wants to Save: Infographic